… that COVID-19 patients with systemic ARDs may be at a higher risk of hospitalization,
ICU admission, acute renal failure, and venous thromboembolism when compared to COVID-19 …

… So far, while first data on COVID-19 vaccine response in immunocompromised patients …
COVID-19 vaccination in patients with various autoimmune inflammatory rheumatic conditions …

… Autoimmunity Standardisation Initiative (EASI) we aimed to provide reliable data on the
extent of the impact of COVID-19 … and autoimmune conditions at the crossroad of COVID-19 …

… Reported flare of the autoimmune condition was evaluated by asking the patient if she/he
experienced symptoms compatible with a flare and if so, which one. A reported flare was …

… Additionally, our data suggest that COVID-19 vaccinations do not seem to trigger autoimmune
… that assessed consequences of mRNA vaccines in patients with autoimmune diseases. …

… to COVID-19 infection. Whilst there is a paucity of long-term safety and efficacy data of
COVID-19 vaccination in patients with autoimmune … of the COVID-19 Vaccination in Autoimmune …

… As concerns about side effects may contribute to COVID-19 vaccine hesitancy and since
immunocompromised individuals were largely excluded from COVID-19 vaccine trials, we …

… A notable aspect of Long COVID-19 is the emergence of new-onset autoimmune diseases
that … Common autoimmune conditions that arise in post-COVID patients include autoimmune …

… Although coronavirus disease 2019 (COVID-19) is mainly … are not at increased risk during
COVID-19; 6 while Chinese data … were only a minority among those infected with COVID-19. …

… COVID-19 in people with rare autoimmune rheumatic conditions compared with the risk outside
COVID-19, … The increased risk of death compared with the pre-COVID risk among people …